| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.35▲ | 0.36▼ | 0.36▼ | 0.37▼ | 0.38▼ |
| MA10 | 0.36▼ | 0.36▼ | 0.36▼ | 0.38▼ | 0.44▼ |
| MA20 | 0.36▼ | 0.36▼ | 0.37▼ | 0.39▼ | 0.74▼ |
| MA50 | 0.37▼ | 0.37▼ | 0.38▼ | 0.44▼ | 1.35▼ |
| MA100 | 0.38▼ | 0.39▼ | 0.39▼ | 0.80▼ | 2.00▼ |
| MA200 | 0.39▼ | 0.40▼ | 0.48▼ | 1.11▼ | 7.39▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.000▼ | 0.000▼ | 0.004▲ | -0.004▼ |
| RSI | 35.862▼ | 35.664▼ | 35.511▼ | 36.087▼ | 36.142▼ |
| STOCH | 0.627▼ | 25.794 | 25.576 | 9.147▼ | 9.740▼ |
| WILL %R | -96.241▼ | -97.175▼ | -97.382▼ | -99.167▼ | -93.478▼ |
| CCI | -66.841 | -88.130 | -100.304▼ | -169.920▼ | -58.290 |
|
Saturday, June 13, 2026 09:12 AM
The score is primarily constrained by weak financial performance (no revenue, persistent net losses, and significant cash burn) despite improved leverage. Technicals also remain negative with price ...
|
|
Wednesday, May 13, 2026 05:00 PM
On April 28, 2026, Soligenix, Inc. (NASDAQ: SNGX) announced interim results from the Phase 3 FLASH2 of HyBryte™ (SGX301 or synthetic hypericin) in the treatment of cutaneous T cell lymphoma (CTCL).
|
|
Monday, April 06, 2026 12:55 PM
Soligenix, Inc. (NASDAQ: SNGX) is currently conducting the Phase 3 FLASH2 Trial of HyBryte™ (SGX301 or synthetic hypericin) in the treatment of cutaneous T cell lymphoma (CTCL). As of the latest ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/07/26 | 0.3564 | 0.3564 | 0.3545 | 0.355 | 226,500 |
| 10/07/26 | 0.3657 | 0.3726 | 0.3571 | 0.3599 | 266,462 |
| 09/07/26 | 0.3748 | 0.3748 | 0.365 | 0.3679 | 364,682 |
| 08/07/26 | 0.38 | 0.3889 | 0.3649 | 0.37 | 488,069 |
| 07/07/26 | 0.3831 | 0.3899 | 0.3793 | 0.3858 | 334,483 |
| 06/07/26 | 0.39 | 0.395 | 0.382 | 0.3848 | 496,888 |
| 02/07/26 | 0.4036 | 0.4102 | 0.386 | 0.387 | 836,098 |
| 01/07/26 | 0.409 | 0.4099 | 0.395 | 0.397 | 540,367 |
| 30/06/26 | 0.4099 | 0.4099 | 0.395 | 0.396 | 318,781 |
| 29/06/26 | 0.4084 | 0.41 | 0.395 | 0.40 | 405,710 |
|
|
||||
|
|
||||
|
|